Coronavirus (COVID-19)

Health Technology Wales (HTW) is working with our partners in health and social care to support the response to the COVID-19 pandemic.

As the COVID-19 situation is rapidly changing, this page will be regularly updated with new information about the ways we’re working and services we offer.

Evidence reviews and research

We can provide rapid evidence summaries, what we call Topic Exploration Reports (TERs), on emerging evidence for COVID-19 diagnostics and therapeutics.

We can also provide high level reviews of telemonitoring technologies and assist with the remote delivery of care.

Our team of researchers are currently checking HTW Guidance and reports, as well as advice from other relevant organisations, on healthcare-relevant solutions for; remote working, remote patient management, workforce management and mobilisation.

We’ll update and republish any HTW reports that are potentially relevant to COVID-19.

Evidence digest

We’ve produced a digest of links to websites which collate or synthesize evidence relating to COVID-19.  This is a quick guide, and therefore not exhaustive, but it will be updated regularly as required.

Click here to read the latest evidence digest.

Scientific advice

Technology developers and companies who are developing therapeutics and diagnostics related to COVID-19 can receive free scientific advice from HTW.

Our advice can help with a number of aspects of health technology assessments, including; evidence collection, evidence generation, economic modelling etc.

Work with HTW

To get in touch with HTW about anything related to our COVID-19 work, email info@healthtechnology.wales or click here to contact us..

We’re inviting COVID-related research questions, evidence reviews and requests for economics support. Organisations involved in Health Technology Assessments (HTA), guidelines and economic modelling are invited to engage with us to see how we can collaborate and share resources.

Changes to how we work

To release front-line staff and avoid distracting the NHS in this time of unprecedented pressure, we’ve suspended our Appraisal Panel meetings and publication of new national Guidance until further notice. Our team will be in touch if you were due to attend these meetings or if it affects a topic you’re involved in.

There may be a slight delay in our response time to more general enquiries. This is because we’re taking steps to restrict all non-essential travel and contact, in line with guidance from public health officials.

News

News

May 2020

£150,000 competition for COVID-19 digital solutions – now open!

Welsh Government have announced a new funding competition for digital solutions to help fight coronavirus disease (COVID-19). Funding is available for between five and eight projects to rapidly pilot products and solutions.

Case Study

May 2020

Case study: COVID-19 Evidence Digest

One of the first tasks Health Technology Wales (HTW) undertook in response to the coronavirus disease (COVID-19) outbreak was to create an ‘evidence digest.’

News

Apr 2020

Health Technology Wales publishes evidence review of COVID-19 diagnostics

This review sets the context for decision makers in Welsh Government, health and social care. It aims to assist their response to the COVID-19 pandemic and facilitate evidence-informed decisions.

More information about coronavirus disease (COVID-19):


Further advice and resources:

  • The All Wales Therapeutics & Toxicology Centre (AWTTC) is providing therapeutic advice to aid the appropriate use of medicines during the COVID-19 pandemic. Click here.
  • Health Information and Quality Authority (HIQA) is providing regular updates about its response to the COVID-19 pandemic. Click here.
  • The National Institute for Health and Care Excellence (NICE) is supporting the NHS and social care to respond quickly to the challenges of the COVID-19 pandemic. Click here.
  • The Scottish Health Technologies Group (SHTG) is highlighting reliable resources that can aid health and care professionals during the COVID-19 pandemic. Click here.